SCHEMBL6158071

SCHEMBL6158071

COc1ccc(C(=O)CN2CCN(C3CCCCO3)C2=O)cc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 13/20 0.50
CBX7 O95931 3/20 0.44
CDYL2 Q8N8U2 3/20 0.44
CDYL Q9Y232 3/20 0.44
CDY1; CDY1B Q9Y6F8 3/20 0.44
MAPT P10636 3/20 0.43
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.43
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
POLB P06746 1/20 0.41
PDE4A P27815 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7371414 0.73 PDE4B (0.45) PDE4BCBX7CDYL2CDYLCDY1; CDY1B
SCHEMBL5563554 0.71 ALDH1A1 (0.55) PDE4BMAPTALDH1A1CYP1A2CYP3A4
SCHEMBL5564330 0.69 PDE4B (0.55) PDE4BCBX7CDYL2CDYLCDY1; CDY1B
SCHEMBL18313965 0.68 ALDH1A1 (0.57) PDE4BMAPTALDH1A1MEN1KMT2A
SCHEMBL22713897 0.67 PDE4B (1.00) PDE4B
SCHEMBL22713918 0.65 PDE4B (1.00) PDE4B
SCHEMBL6073307 0.65 MAPK1 (0.55) MAPTALDH1A1
SCHEMBL22714024 0.65 PDE4B (1.00) PDE4B
SCHEMBL22713955 0.65 PDE4B (1.00) PDE4B
SCHEMBL7285107 0.65 CTNNB1 (0.58) PDE4BMAPTALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832071-B1 1,3-DIHYDRO-2H-IMIDAZOL-2-ONE DERIVATIVES HAVING PDE IV AND CYTOKININ INHIBITING ACTIVITY JANSSEN PHARMACEUTICA NV (BE) 2005-09-28 EP disclosed
US-5869515-A TREATING ASTHMATIC OR ATOPIC DISEASES JANSSEN PHARMACEUTICA N.V. (BE) 1999-02-09 US disclosed
EP-0832071-A1 1,3-DIHYDRO-2H-IMIDAZOL-2-ONE DERIVATIVES HAVING PDE IV AND CYTOKININ INHIBITING ACTIVITY JANSSEN PHARMACEUTICA N.V. (BE) 1998-04-01 EP disclosed
WO-1996031487-A1 1,3-DIHYDRO-2H-IMIDAZOL-2-ONE DERIVATIVES HAVING PDE IV AND CYTOKININ INHIBITING ACTIVITY JANSSEN PHARMACEUTICA N.V. (BE) 1996-10-10 WO disclosed